COVID-19
Clinical Recommendations and Patient Hub
Resource Center
Welcome to our COVID-19 Resource Center – bringing together all relevant lectures and data from our COVID-19 programs.
Browse through the latest recommendations from key experts on therapeutics, variants, vaccines, and epidemiology.
Hear the lived experiences of people living with long COVID and how they can best be supported.
This content is freely accessible and brings together all relevant lectures and data from our COVID-19 programs.
Quick links
Prevention & Vaccines
Clinical Management
Therapeutics
Origins and Variants
Public Health
Long-COVID
Long COVID Prevalence, Incidence, and Risk Factors
Monica Gandhi, MD, PhD.
Defining the Syndrome and Clusters of Symptoms
Andrea Foulkes, ScD.
Where the Gaps Are?
Helen Ward, PhD, MBChB, MSc, FFFPH, FRCP
Long COVID Pathogenesis - What Have We Learned So Far?
Roger Paredes, MD, PhD.
Mitochondrial Dysfunction - COVID, Muscles, and Mitochondria
Brent Appleman, MD.
Long COVID and Vascular Dysfunction
Etheresia Pretorius, PhD.
SARS-CoV-2 Adaptive Immune Responses in Long COVID
Lisa Chakrabarti, PhD.
The Hamster Model for Studying the Neurological Manifestations of Long COVID
Guilherme Dias de Melo, DVM, MSc, PhD.
Current Treatment Options
Dominique Salmon, MD, PhD.
Rehabilitation and Post-exertional Malaise Management
Fanny Brunet, PhD.
Neurocognitive and Neurological Symptoms
Mayssam Nehme, MD.
COVID-OUT Study
Carolyn Bramante, MD, PhD.
Revisiting Post-Acute COVID-19 Syndrome
Ziyad Al-Aly, MD, FASN
Long COVID (Post-Acute COVID-19 Syndrome)
Susan Swindels, MBBS
Long COVID: What Have We Learned So Far?
Carlos del Rio, MD
Clinical Management of Long COVID
Carlos del Rio, MD
Global Burden of Long COVID
Sarah Wulf Hanson, PhD, MPH
Paxlovid for the Treatment of Long COVID
Harlan Krumholz, MD
Prevention & Vaccines
COVID-19 Vaccines - State of the Art
Kathryn Stephenson, MD, MPH
Immune Correlates of Protection from SARS-CoV-2 Infection
Miles Philip Davenport, MB BS, D.Phil
Infection-Induced and Hybrid Immunity
Jefferson Jones, MD, MPH, LCDR USPHS
Vaccine Landscape
Kathryn Stephenson, MD, MPH
Vaccine Responses in People Living with HIV
Casper Rokx, MD, PhD
Vaccine Hesitancy
Scott C. Ratzan MD, MPA, MA
Newly Approved and Rolled Out Vaccines
Kathleen Neuzil, MD
Immunogenicity of the New and Modified Boosters
Angela Branche, MD
Vaccine Protection within the School Setting
Westyn Branch-Elliman, MD, MMSc
COVID-19 Prevention - Do We Need Subtype-Specific Vaccine?
Kathyryn Stephenson, MD, MPH.
Updated Recommendations for SARS-CoV-2 Vaccination
Kathyryn Stephenson, MD, MPH.
Transmission
COVID-19 Vaccines: Impact and Effectiveness in Preventing Infection and Transmission
Eyal Leshem, MD
Clinical Trial Design and Analytic Strategies for Evaluating COVID Vaccine Effects on Transmission
Holly Janes, PhD
Scheduling and Boosting
Post-Vaccination Infection
Post-vaccination Infection with SARS-CoV-2
Ravindra Gupta, MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSci
Safety
Vaccine Responses in the Key Populations
François Venter, MD, FCP, PhD
Myocarditis and COVID-19 Vaccination
Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
Thrombosis and COVID-19 Vaccination
Steven Kerr, PhD
COVID-19 Vaccination in Pregnant and Lactating Individuals
Ai-ris Yonekura Collier, MD
Pediatric Vaccinations
C. Buddy Creech, MD, MPH, FPIDS
Vaccine-Related Adverse Events / Long-Term Data
John R. Su, MD, PhD, MPH
Key Populations: Immunocompromised and High-Risk Patients
SARS-CoV-2 Immunity in People with HIV and Other Immunosuppressed Individuals
John Frater, FRCP, PhD
Strategies to Vaccinate Immunocompromised Patients
Anna Maria Geretti, MD, PhD, FRCPath
Vaccination in Immunocompromised Patients: How to Optimize Protection
Camille Kotton, MD, FIDSA, FAST
Update on Prevention and Treatment of COVID-19 in Immunocompromised Populations
Jonathan Li, MD
Access and Challenges for LMIC
Challenges to Global Access Equity
Linda-Gail Bekker, MBCHB, DTMH, DCH, FCP(SA), PhD
Vaccinating as Fast as Possible – Challenges for LMICs
Claudia Cortes, MD
Diagnostics in LMICs, and Adapted for Variants
Update on SARS-CoV-2 Virological Diagnostics
Anne-Geneviève Marcelin, MD
Diagnostic Challenges in LMICs
Rosanna Peeling, PhD
Adapting Diagnostics to SARS-CoV-2 Viral Variants
Annemarie Wensing, MD, PhD
Clinical Manifestations & Management
Clinical Management of COVID-19 in High-risk Populations
Claudia Cortes, MD
COVID Infusion Therapy
Jeremiah Olivas, MSN, AG-ACNP
Drug-Drug Interactions
Catia Marzolini, PharmD, PhD
Complications of Acute COVID-19
Complications of Acute COVID-19
Otavio Berwanger, MD, PhD
Acute COVID-19 and Predictors of Outcome
Lloyd Mulenga, BScHb, MBChB, MSc, MMed, PhD
COVID-19 Challenging Cases
Daniel Kuritzkes, MD
Pediatric Manifestations
Pediatric Manifestations of COVID-19
Jeffrey Vergales, MD, MS
Respiratory Management
Respiratory Management of COVID-19
Vikram Mukherjee, MD, FRCP(Edin)
Clinical Respiratory Management in LMICs
Ary Serpa Neto, MD, MSc, PhD
Therapeutics
Update on COVID-19 Therapeutics
Daniel Kuritzkes, MD
Update on COVID-19 Therapeutics
Daniel Kuritzkes, MD
Update on COVID-19 Therapeutics (March 2023)
Daniel Kuritzkes, MD
Update on Therapeutics (May 2023)
Daniel Kuritzkes, MD
Update on Therapeutics (October 2023)
Daniel Kuritzkes, MD
Monoclonal Antibodies
Monoclonal Antibodies for SARS-CoV-2
Katharine Bar, MD
Immunomodulating Therapies
Immunomodulating Therapies
Karine Lacombe, MD, PhD
SARS-CoV-2 Origins and Variants
Current Status of the Most Dominant SARS-CoV2 Variant
Penny Moore, PhD
Origins
The WHO Global Study of the Origins of SARS-CoV-2
Dominic Dwyer, BSc(Med), MBBS, MD
Variants and Disease Severity
SARS-CoV-2 Variants and Disease Severity
Robert Shafer, MD
Omicron
The Omicron Variant: Genetic Make-up and Spread
Penny Moore, PhD
The Omicron Variant: Lessons Learned & Preparedness for Next Waves
Laila Woc-Colburn, MD, DTM&H, FIDSA
Public Health
How to Convey Messages About Vaccine Safety
Margie Danchin, MBBS, PhD, FRACP
A Multinational Delphi Consensus to End the COVID-19 Public Health Threat
Jeffrey Lazarus, PhD, MIH, MA
A Mask Is Not a Mask - Why Some Facemasks Are Better Than Others
Jose-Luis Jimenez, PhD
Immunity Due to the Previous Infection
Carlos del Rio, MD
Vaccination Requirements - Countries & Company Policies
Michel Kazatchkine, MD
Masks and Other Non-Pharmaceutical Interventions- Is It Time to Return to Our Pre-Pandemic Ways?
Shira Doron, MD, FIDSA
Pros and Cons of Global Roll-Out
Oliver Watson, PhD
Clinical, Public Health, and Behavioral Aspects of COVID-19 in China and Implications for the World
Joseph Tucker, MD, PhD, AM
Hybrid Immunity to SARS-CoV-2 - The New Normal
Penny Moore, PhD
Surveillance and Public Health Measures for LMICs
Surveillance and Public Health Measures for LMICs
Waasila Jassat, MBBCh, MMed, FCPHM
The material provided here is meant for educational purposes only.
